Feb 16, 2023 / 10:00PM GMT
Operator
Good afternoon, ladies and gentlemen. Thank you for attending today's Bio-Rad Fourth Quarter and Full Year 2022 Earnings Results Conference Call. My name is Tia, and I will be your moderator for today's call. (Operator Instructions)
I would now like to pass the conference over to your host, Edward Chung with Bio-Rad. Please proceed.
Yong Chung - Bio-Rad Laboratories, Inc. - VP of IR
Thanks, Tia. Good afternoon, everyone, and thank you for joining us today. Today, we will review the fourth quarter and full year 2022 financial results and provide an update on key business trends for Bio-Rad. With me on the call today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Simon May, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.
Before we begin our review, I'd like to caution everyone that we will be making forward-looking statements about management's goals, plans and
Q4 2022 Bio Rad Laboratories Inc Earnings Call Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers